Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy (RICTOR_SC)
KCT0003954Phase 2Withdrawn
- Sponsor
- Ministry of Health & Welfare
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of vistusertib in Nonhematologic neoplasms and cancer, sponsored by Ministry of Health & Welfare. Planned start May 2019; status: withdrawn.
02
Drugs
vistusertib
03
Conditions
Nonhematologic neoplasmscancer
Beyond the preview
Go deeper on KCT0003954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003954.